Company Performance: Revenue, profit margins, debt levels, and future growth prospects all influence investor sentiment and stock valuation.

Industry Trends: The overall health and outlook of the pharmaceutical and biotech industry impact investor confidence in companies within the sector.

Market Sentiment: General investor optimism or pessimism, driven by economic conditions or geopolitical events, can affect stock prices broadly.

Regulatory Changes: Government regulations, drug approvals, and healthcare policies significantly impact pharmaceutical companies' revenue and profitability.

Competition: The presence of competing products or companies can influence market share and pricing power, impacting stock valuation.

Economic Factors: Interest rates, inflation, and economic growth rates influence investment decisions and overall market valuations.

Financial Reports: Earnings releases, annual reports, and other financial disclosures provide insights into company performance and future prospects, driving price movements.

Dividend Policy: Changes in dividend payouts can affect investor demand for the stock, particularly among income-seeking investors.

News & Events: Company-specific news, such as clinical trial results, mergers, or acquisitions, can cause significant price fluctuations.

Global Events: Pandemics, political instability, and international trade policies can impact global supply chains and market sentiment.

Analyst Ratings: Investment bank analysts' ratings and price targets can influence investor perception and trading activity.

Investor Sentiment: Investor confidence and risk appetite play a crucial role in determining stock prices, especially for growth stocks.